Enveric Biosciences (ENVB) EBT Margin Growth (3y) (2017 - 2020)
Enveric Biosciences (ENVB) EBT Margin Growth (3y) (2017 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -484.00 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 132.00 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 6,685.00 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -2,054.00 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8,006.00 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 9,980.00 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 31,363.00 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | -5,319.00 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -9,922.00 |
| 10 | Enveric Biosciences | 5.42 Mn | -2.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 2,075.00 |
| Jun 30, 2020 | 776.00 |
| Mar 31, 2020 | -1,248.00 |
| Dec 31, 2019 | -375.00 |
| Sep 30, 2019 | 1,811.00 |
| Jun 30, 2019 | 682.00 |
| Mar 31, 2019 | -208.00 |
| Dec 31, 2018 | -10,703.00 |
| Sep 30, 2018 | 6,259.00 |
| Jun 30, 2018 | -1,531.00 |
| Mar 31, 2018 | -3,934.00 |
| Jun 30, 2017 | -4,079.00 |